Oxford BioMedica (OTCMKTS:OXBDF) Reaches New 1-Year Low – What’s Next?
by Tristan Rich · The Markets DailyOxford BioMedica (OTCMKTS:OXBDF – Get Free Report) shares reached a new 52-week low during mid-day trading on Wednesday . The company traded as low as $5.80 and last traded at $5.9966, with a volume of 6505 shares trading hands. The stock had previously closed at $5.89.
Analysts Set New Price Targets
Separately, Zacks Research upgraded Oxford BioMedica to a “hold” rating in a research note on Wednesday, July 22nd. One equities research analyst has rated the stock with a Hold rating, According to MarketBeat, the company currently has a consensus rating of “Hold”.
Read Our Latest Stock Report on OXBDF
Oxford BioMedica Trading Up 1.8%
The firm’s 50-day moving average price is $7.37 and its two-hundred day moving average price is $7.86.
About Oxford BioMedica
Oxford BioMedica plc is a United Kingdom-based contract development and manufacturing organization (CDMO) focused on cell and gene therapies. The company helps biotechnology and pharmaceutical customers develop, test, and manufacture advanced therapies, with expertise in viral-vector technologies used to deliver genetic material into cells.
Its services include process and analytical development, clinical and commercial manufacturing, quality testing, regulatory support, and related research services.